當(dāng)前位置：首頁(yè) JCRQ1 期刊介紹(非官網(wǎng))

World Journal Of Surgical OncologySCIE

國(guó)際簡(jiǎn)稱：WORLD J SURG ONCOL 參考譯名：世界腫瘤外科雜志

中科院分區(qū)
3區(qū)
CiteScore分區(qū)
Q1
JCR分區(qū)
Q1

基本信息：: ISSN：1477-7819; E-ISSN：1477-7819; 是否OA：開(kāi)放; 是否預(yù)警：否; TOP期刊：否

出版信息：: 出版地區(qū)：ENGLAND; 出版商：BioMed Central; 出版語(yǔ)言：English; 出版周期：Irregular; 出版年份：2003; 研究方向：ONCOLOGY-SURGERY

評(píng)價(jià)信息：: 影響因子：2.5; H-index：48; CiteScore指數(shù)：4.7; SJR指數(shù)：0.733; SNIP指數(shù)：0.921

發(fā)文數(shù)據(jù)：: Gold OA文章占比：100.00%; 研究類文章占比：85.90%; 年發(fā)文量：376; 自引率：0.1562...; 開(kāi)源占比：0.9972; 出版撤稿占比：0; 出版國(guó)人文章占比：0.46; OA被引用占比：1

投稿咨詢加急見(jiàn)刊

英文簡(jiǎn)介期刊介紹 CiteScore數(shù)據(jù) 中科院SCI分區(qū) JCR分區(qū) 發(fā)文數(shù)據(jù) 常見(jiàn)問(wèn)題

英文簡(jiǎn)介World Journal Of Surgical Oncology期刊介紹

World Journal of Surgical Oncology publishes articles related to surgical oncology and its allied subjects, such as epidemiology, cancer research, biomarkers, prevention, pathology, radiology, cancer treatment, clinical trials, multimodality treatment and molecular biology. Emphasis is placed on original research articles. The journal also publishes significant clinical case reports, as well as balanced and timely reviews on selected topics.

Oncology is a multidisciplinary super-speciality of which surgical oncology forms an integral component, especially with solid tumors. Surgical oncologists around the world are involved in research extending from detecting the mechanisms underlying the causation of cancer, to its treatment and prevention. The role of a surgical oncologist extends across the whole continuum of care. With continued developments in diagnosis and treatment, the role of a surgical oncologist is ever-changing. Hence, World Journal of Surgical Oncology aims to keep readers abreast with latest developments that will ultimately influence the work of surgical oncologists.

期刊簡(jiǎn)介World Journal Of Surgical Oncology期刊介紹

《World Journal Of Surgical Oncology》自2003出版以來(lái)，是一本醫(yī)學(xué)優(yōu)秀雜志。致力于發(fā)表原創(chuàng)科學(xué)研究結(jié)果，并為醫(yī)學(xué)各個(gè)領(lǐng)域的原創(chuàng)研究提供一個(gè)展示平臺(tái)，以促進(jìn)醫(yī)學(xué)領(lǐng)域的的進(jìn)步。該刊鼓勵(lì)先進(jìn)的、清晰的闡述，從廣泛的視角提供當(dāng)前感興趣的研究主題的新見(jiàn)解，或?qū)彶槎嗄陙?lái)某個(gè)重要領(lǐng)域的所有重要發(fā)展。該期刊特色在于及時(shí)報(bào)道醫(yī)學(xué)領(lǐng)域的最新進(jìn)展和新發(fā)現(xiàn)新突破等。該刊近一年未被列入預(yù)警期刊名單，目前已被權(quán)威數(shù)據(jù)庫(kù)SCIE收錄，得到了廣泛的認(rèn)可。

該期刊投稿重要關(guān)注點(diǎn)：

預(yù)計(jì)審稿時(shí)間：約3月
醫(yī)學(xué)
ONCOLOGY
SCIE
中科院3區(qū)
非預(yù)警

Cite Score數(shù)據(jù)（2024年最新版）World Journal Of Surgical Oncology Cite Score數(shù)據(jù)

CiteScore：4.7
SJR：0.733
SNIP：0.921

學(xué)科類別	分區(qū)	排名	百分位
大類：Medicine 小類：Surgery	Q1	96 / 551	82%
大類：Medicine 小類：Oncology	Q2	180 / 404	55%

CiteScore 是由Elsevier(愛(ài)思唯爾)推出的另一種評(píng)價(jià)期刊影響力的文獻(xiàn)計(jì)量指標(biāo)。反映出一家期刊近期發(fā)表論文的年篇均引用次數(shù)。CiteScore以Scopus數(shù)據(jù)庫(kù)中收集的引文為基礎(chǔ)，針對(duì)的是前四年發(fā)表的論文的引文。CiteScore的意義在于，它可以為學(xué)術(shù)界提供一種新的、更全面、更客觀地評(píng)價(jià)期刊影響力的方法，而不僅僅是通過(guò)影響因子(IF)這一單一指標(biāo)來(lái)評(píng)價(jià)。

歷年Cite Score趨勢(shì)圖

中科院SCI分區(qū)World Journal Of Surgical Oncology 中科院分區(qū)

中科院 2023年12月升級(jí)版 綜述期刊：否 Top期刊：否

大類學(xué)科	分區(qū)	小類學(xué)科	分區(qū)
醫(yī)學(xué)	3區(qū)	ONCOLOGY 腫瘤學(xué) SURGERY 外科	3區(qū) 3區(qū)

中科院分區(qū)表 是以客觀數(shù)據(jù)為基礎(chǔ)，運(yùn)用科學(xué)計(jì)量學(xué)方法對(duì)國(guó)際、國(guó)內(nèi)學(xué)術(shù)期刊依據(jù)影響力進(jìn)行等級(jí)劃分的期刊評(píng)價(jià)標(biāo)準(zhǔn)。它為我國(guó)科研、教育機(jī)構(gòu)的管理人員、科研工作者提供了一份評(píng)價(jià)國(guó)際學(xué)術(shù)期刊影響力的參考數(shù)據(jù)，得到了全國(guó)各地高校、科研機(jī)構(gòu)的廣泛認(rèn)可。

中科院分區(qū)表 將所有期刊按照一定指標(biāo)劃分為1區(qū)、2區(qū)、3區(qū)、4區(qū)四個(gè)層次，類似于“優(yōu)、良、及格”等。最開(kāi)始，這個(gè)分區(qū)只是為了方便圖書管理及圖書情報(bào)領(lǐng)域的研究和期刊評(píng)估。之后中科院分區(qū)逐步發(fā)展成為了一種評(píng)價(jià)學(xué)術(shù)期刊質(zhì)量的重要工具。

歷年中科院分區(qū)趨勢(shì)圖

JCR分區(qū)World Journal Of Surgical Oncology JCR分區(qū)

2023-2024 年最新版

按JIF指標(biāo)學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：ONCOLOGY	SCIE	Q3	183 / 322	43.3%
學(xué)科：SURGERY	SCIE	Q1	68 / 290	76.7%

按JCI指標(biāo)學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：ONCOLOGY	SCIE	Q2	85 / 322	73.76%
學(xué)科：SURGERY	SCIE	Q2	77 / 290	73.62%

JCR分區(qū)的優(yōu)勢(shì)在于它可以幫助讀者對(duì)學(xué)術(shù)文獻(xiàn)質(zhì)量進(jìn)行評(píng)估。不同學(xué)科的文章引用量可能存在較大的差異，此時(shí)單獨(dú)依靠影響因子(IF)評(píng)價(jià)期刊的質(zhì)量可能是存在一定問(wèn)題的。因此，JCR將期刊按照學(xué)科門類和影響因子分為不同的分區(qū)，這樣讀者可以根據(jù)自己的研究領(lǐng)域和需求選擇合適的期刊。

歷年影響因子趨勢(shì)圖

發(fā)文數(shù)據(jù)

2023-2024 年國(guó)家/地區(qū)發(fā)文量統(tǒng)計(jì)

國(guó)家/地區(qū)數(shù)量
CHINA MAINLAND403
Japan125
USA43
GERMANY (FED REP GER)41
South Korea26
Italy21
Taiwan19
India15
Poland14
France13

本刊中國(guó)學(xué)者近年發(fā)表論文

1、RBM14 as a novel epigenetic-activated tumor oncogene is implicated in the reprogramming of glycolysis in lung cancer
Author: Hu, Yan; Mu, Hanshuo; Deng, Zhiping

Journal: WORLD JOURNAL OF SURGICAL ONCOLOGY. 2023; Vol. 21, Issue 1, pp. -. DOI: 10.1186/s12957-023-02928-8
2、Current perspectives on cell-assisted lipotransfer for breast cancer patients after radiotherapy
Author: Wu, Qiuwan; Chen, Shuai; Peng, Wuyun; Chen, Donghan

Journal: WORLD JOURNAL OF SURGICAL ONCOLOGY. 2023; Vol. 21, Issue 1, pp. -. DOI: 10.1186/s12957-023-03010-z
3、Junior surgeons are quicker to master the single-port thoracoscopic lobectomy: comprehensive analysis of the learning curve and oncological outcomes
Author: Liang, Mingqiang; Wu, Peixun; Xu, Chi; Zheng, Bin; Chen, Chun

Journal: WORLD JOURNAL OF SURGICAL ONCOLOGY. 2023; Vol. 21, Issue 1, pp. -. DOI: 10.1186/s12957-023-03017-6
4、Sublobar resection versus lobectomy in the treatment of synchronous multiple primary lung cancer
Author: Niu, Niu; Zhou, Liang; Zhao, Junjie; Ma, Xingjie; Yang, Fan; Qi, Weibo

Journal: WORLD JOURNAL OF SURGICAL ONCOLOGY. 2023; Vol. 21, Issue 1, pp. -. DOI: 10.1186/s12957-023-02996-w
5、Impact of endoscopic metallic stent placement and emergency surgery on detection of viable circulating tumor cells for acute malignant left-sided colonic obstruction
Author: Ni, Zhizhan; Cao, Yuepeng; Liu, Liming; Huang, Chenshen; Xie, Huahao; Zhou, Jinzhe; Ge, Bujun; Huang, Qi

Journal: WORLD JOURNAL OF SURGICAL ONCOLOGY. 2023; Vol. 21, Issue 1, pp. -. DOI: 10.1186/s12957-022-02879-6
6、Prognostic significance of pretreatment systemic immune-inflammation index in patients with prostate cancer: a meta-analysis
Author: Zhang, Buwen; Xu, Tao

Journal: WORLD JOURNAL OF SURGICAL ONCOLOGY. 2023; Vol. 21, Issue 1, pp. -. DOI: 10.1186/s12957-022-02878-7
7、Gene signature and prognostic value of ubiquitination-related genes in endometrial cancer
Author: Wang, Ziwei; Cheng, Shuangshuang; Liu, Yan; Zhao, Rong; Zhang, Jun; Zhou, Xing; Shu, Wan; Feng, Dilu; Wang, Hongbo

Journal: WORLD JOURNAL OF SURGICAL ONCOLOGY. 2023; Vol. 21, Issue 1, pp. -. DOI: 10.1186/s12957-022-02875-w
8、Transcriptome analysis reveals the differential inflammatory effects between propofol and sevoflurane during lung cancer resection: a randomized pilot study
Author: Wang, Sufang; Li, Mengjiao; Cai, Suna; Zhang, Wei

Journal: WORLD JOURNAL OF SURGICAL ONCOLOGY. 2023; Vol. 21, Issue 1, pp. -. DOI: 10.1186/s12957-023-02891-4